Medical Equipment News | Medical XPRT

Showcase

Olansi air purifier review : Can Olansi Air Purifiers Help Avoid Allergies?

This is one of the most questions about air purifiers. Most people wonder if AP air purifiers can help them with allergies. In this article, we are going to talk about this question. The short answer is, yes these units can help avoid allergies caused by dust, dander, and pet hair. Read on to find out. First of all, we should talk about the most common household allergens that can be found in ...

Sep. 10, 2021

By Olansi Healthcare Co.,Ltd

Exosome Targeting Services at Creative Biolabs Ready to Boost Drug Delivery Research

Exosomes are picking up steam among scientists because they can perform a role in the immune response, antigen presentation, cell migration, cell differentiation, and tumor invasion. Exosomes, which provide a mechanism for macromolecules to be exchanged between cells, play a part in the development of various illnesses, particularly in the modulation of the cancer microenvironment and immune ...

Sep. 1, 2021

By Creative Biolabs

Philippe Deecke appointed as Chief Financial Officer of Lonza Group

Lonza appoints Philippe Deecke as CFO and member of the Lonza Group Executive Committee Philippe brings a wealth of experience from a 30-year career, which includes senior leadership roles in Novartis finance and time working as a McKinsey consultant He will commence his tenure with Lonza Group on 1 December 2021 Philippe succeeds Rodolfo J. Savitzky, who leaves Lonza Group for a new ...

Aug. 26, 2021

By Lonza Group Ltd

Creative Proteomics Offers Untargeted Metabolomics Service for Academia and Various Industries

Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. Creative Proteomics has deep industry and business process expertise, global resources, and a good reputation in providing contract services specialized for metabolomics. Recently, the company ...

Aug. 18, 2021

By Creative Proteomics

Avery Biomedical Letter to Medscape Regarding Diaphragm Pacing

Please find below a letter that our attorney sent to the editors of Medscape (parent company WebMD) who have published false information about our product. Medscape Letter Regarding Avery System Avery Biomedical Devices has an outstanding track record spanning over 45 years including an outstanding safety record, long term viability with some patients pacing for more than 35 years, and ...

Aug. 13, 2021

By Avery Biomedical Devices, Inc.

Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available

Avery Biomedical Devices (Commack, NY), the global leader in high reliability diaphragm pacemakers, announced that its new diaphragm pacemaker transmitter, Spirit, has earned FDA approval and is now being offered to patients using its pacing system. This NextGen transmitter features a light-weight compact design with easy-to-use touch controls and offers precision-enhancing digital ...

Aug. 13, 2021

By Avery Biomedical Devices, Inc.

Orgenesis to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021

Orgenesis Inc. (NASDAQ:ORGS), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Thursday, August 19 at 8:00 am ET. Vered Caplan, CEO of Orgenesis, will be hosting the presentation and answering questions from investors. To access the live presentation, please use the ...

Aug. 12, 2021

By Orgenesis

BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2021 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2021 with the Securities and Exchange Commission. Q2 and Recent Business Highlights: ...

Aug. 12, 2021

By Biocardia, Inc.

Lonza and Sheba Medical Center Use Cocoon® Platform and Show Successful Clinical Outcomes in Patients Treated with CAR-T Cell Immunotherapy

Four patients have been successfully dosed at Sheba Medical Center, Israel, with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon® automated manufacturing Platform The data underscores the capability of Cocoon® to successfully manufacture immunotherapies at the point-of-care Three patients had complete responses, with another patient still under evaluation Tel Aviv, ...

Aug. 12, 2021

By Lonza Group Ltd

Flat Medical announced FDA 510(k) clearance of EpiFaith, the Epidural Safety Solution

Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution. Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, which is indicated for painless labor, ...

Aug. 7, 2021

By Flat Medical

Christie Med Announces New Authorized Partner in Al Zahrawi for UAE Distribution of VeinViewer

As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the-USA, VeinViewer® Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of ...

Jul. 28, 2021

By Christie Medical Holdings, Inc.

Koning Goes Live on Investment Platform, Revere

Koning Corporation is now live on the investment platform, Revere, which specializes in raising funds for scalable, high-value technology companies. “We’re excited to bring this opportunity to investors who believe, like we do, in the advancement of women’s health through better breast imaging techniques,” says Koning’s US CEO, Lutao Ning. “We believe that ...

Jul. 22, 2021

By Koning Corporation

Kurin, Inc. announces results on Kurin efficacy from Oishei Children`s Hospital with zero blood culture

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that Oishei Children’s Hospital, a member of Kaleida Health, in Buffalo, NY, presented their findings on their use of Kurin at the recent Association for Professionals in Infection Control conference. This is the first study of Kurin, a passive low-volume blood culture ...

Jul. 21, 2021

By Kurin, Inc.

Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed

First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for ...

Jul. 20, 2021

By Femasys Inc.

BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson`s Disease

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for DA01 for advanced Parkinson’s disease (PD). DA01, BlueRock’s pluripotent stem cell-derived dopaminergic neuron therapy, is under evaluation in a Phase 1 study. The FDA’s ...

Jul. 19, 2021

By BlueRock Therapeutics

Borealis appoints IMCD as Bormed healthcare portfolio distributor

Distribution agreement to take effect as of 1 October 2021 New agreement applies to Bormed™ portfolio of innovative polyolefin grades for healthcare Complementary Borealis and IMCD product portfolios to enable even more choice in polymers Borealis announces that it has selected IMCD, a global leader in the distribution of specialty chemicals and ingredients, as its new European ...

Jul. 13, 2021

By Borealis AG

Merck and INBRAIN Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies

Innovation Center project of Merck collaborates to develop smart neuro-modulation for targeted treatment of chronic diseases. Joint development agreement represents a promising step towards a highly selective and efficient next generation of bioelectronic therapies powered by graphene. INBRAIN Neuroelectronics, a company at the intersection of medtech, deeptech and digital health ...

Jul. 8, 2021

By Inbrain Neuroelectronics

Thermo Fisher Scientific Expands Corporate Leadership Team

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Alan Sachs, who has served as chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E. Nelson, previously president of the J. Craig Venter Institute. Both will join the company leadership team in August 2021. ...

Jul. 7, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies

RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan’s Ministry of Health, Labour, and Welfare (MHLW) for approval to manufacture the Company’s RCT-01 cell therapy for ...

Jul. 7, 2021

By RepliCel Life Sciences

The Chinese University of Hong Kong and Aurora Medical Technology Hong Kong to collaborate on breast cancer research program

Aurora Medical Technology Hong Kong (Aurora-HK) and The Chinese University of Hong Kong (CUHK) are pleased to announce the completion of a landmark collaboration agreement leveraging the shared interests and diverse expertise of the two entities. Led by Winnie chiu-wing Chu MD, Professor of radiology at CUHK and Abraham Morse MD, Medical Director of Aurora, the joint project will investigate the ...

Jun. 28, 2021

By Aurora Healthcare US Corp.